Anus | Breast | Colon | Esophagus | Larynx | Lip, Oral Cavity and Pharynx | Liver | Lung | Other Digestive Organ | Pancreas | Phase I | Rectum | Small Intestine | Stomach | Thyroid, Phase I
An Open-label, Phase 1a/b, Multicenter Study of ZL-6201 to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy in Participants With Sarcoma and Selected Solid Tumors
Volunteers
Health Professionals
What is the purpose of this trial?
The purpose of this study is to evaluate the safety and tolerability of investigational study drug ZL-6201 for treating sarcoma and solid tumors cancer.
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Last Updated07/15/2026
- Study IRB#2000042336